FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3007727516> ?p ?o ?g. }

• W3007727516 abstract "As the number of indicated malignancies for which immune checkpoint inhibitor therapy such as pembrolizumab grows the descriptions of associated immune-related adverse events (irAEs) increases as well. On rare occasions immunotherapy can lead to development of Hemophagocytic Lymphohistiocytosis (HLH) which is a potentially lethal inflammatory disorder characterized by histiocyte activation and cytokine storm. At this time no cases of HLH developing in head and neck squamous cell carcinoma (HNSCC) patients receiving pembrolizumab have been reported.Here we describe the first documented case of pembrolizumab-induced HLH in a 61 year-old male with metastatic HNSCC after having received multiple prior cycles of pembrolizumab without event. Following cycle 14 the patient developed fever associated with new pancytopenia and transaminitis prompting hospital admission. Infectious workup was negative, his metastatic lesions were found to be stable, and there was no evidence of new malignancy. Further workup demonstrated hyperferritinemia and bone marrow biopsy demonstrated hemophagocytosis concerning for pembrolizumab-induced HLH. Etoposide and dexamethasone therapy was initiated leading to clinical improvement and safe discharge.Immunotherapy is a groundbreaking therapeutic intervention for patients with malignancy, however by nature of their mechanism carry a risk of inflammatory side effects. In rare circumstances these inflammatory reactions include potentially deadly syndromes such as HLH. As immunotherapeutics such as pembrolizumab become more widely utilized increased awareness of complications such as HLH is clinically relevant." @default.
• W3007727516 created "2020-03-06" @default.
• W3007727516 creator A5007743619 @default.
• W3007727516 creator A5014160666 @default.
• W3007727516 creator A5057841606 @default.
• W3007727516 creator A5058202332 @default.
• W3007727516 creator A5075324403 @default.
• W3007727516 date "2020-02-03" @default.
• W3007727516 modified "2023-09-27" @default.
• W3007727516 title "Pembrolizumab-induced Hemophagocytic Lymphohistiocytosis: an immunotherapeutic challenge" @default.
• W3007727516 cites W1574141134 @default.
• W3007727516 cites W2043240738 @default.
• W3007727516 cites W2076560655 @default.
• W3007727516 cites W2081414355 @default.
• W3007727516 cites W2088399131 @default.
• W3007727516 cites W2144510654 @default.
• W3007727516 cites W2155477306 @default.
• W3007727516 cites W2162251899 @default.
• W3007727516 cites W2325441109 @default.
• W3007727516 cites W2419486185 @default.
• W3007727516 cites W2532349593 @default.
• W3007727516 cites W2601000668 @default.
• W3007727516 cites W2757190301 @default.
• W3007727516 cites W2768429453 @default.
• W3007727516 cites W2786816161 @default.
• W3007727516 cites W2790123356 @default.
• W3007727516 cites W2807441801 @default.
• W3007727516 cites W2831487285 @default.
• W3007727516 cites W2883196345 @default.
• W3007727516 cites W2895463588 @default.
• W3007727516 cites W2917423789 @default.
• W3007727516 cites W2919226937 @default.
• W3007727516 cites W2925026141 @default.
• W3007727516 doi "https://doi.org/10.1186/s41199-020-0050-3" @default.
• W3007727516 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6996173" @default.
• W3007727516 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32025343" @default.
• W3007727516 hasPublicationYear "2020" @default.
• W3007727516 type Work @default.
• W3007727516 sameAs 3007727516 @default.
• W3007727516 citedByCount "20" @default.
• W3007727516 countsByYear W30077275162020 @default.
• W3007727516 countsByYear W30077275162021 @default.
• W3007727516 countsByYear W30077275162022 @default.
• W3007727516 countsByYear W30077275162023 @default.
• W3007727516 crossrefType "journal-article" @default.
• W3007727516 hasAuthorship W3007727516A5007743619 @default.
• W3007727516 hasAuthorship W3007727516A5014160666 @default.
• W3007727516 hasAuthorship W3007727516A5057841606 @default.
• W3007727516 hasAuthorship W3007727516A5058202332 @default.
• W3007727516 hasAuthorship W3007727516A5075324403 @default.
• W3007727516 hasBestOaLocation W30077275161 @default.
• W3007727516 hasConcept C126322002 @default.
• W3007727516 hasConcept C143998085 @default.
• W3007727516 hasConcept C203014093 @default.
• W3007727516 hasConcept C2777701055 @default.
• W3007727516 hasConcept C2779079688 @default.
• W3007727516 hasConcept C2779134260 @default.
• W3007727516 hasConcept C2779382419 @default.
• W3007727516 hasConcept C2779399171 @default.
• W3007727516 hasConcept C2779559532 @default.
• W3007727516 hasConcept C2780007613 @default.
• W3007727516 hasConcept C2780030458 @default.
• W3007727516 hasConcept C2780057760 @default.
• W3007727516 hasConcept C3008058167 @default.
• W3007727516 hasConcept C524204448 @default.
• W3007727516 hasConcept C71924100 @default.
• W3007727516 hasConcept C8891405 @default.
• W3007727516 hasConceptScore W3007727516C126322002 @default.
• W3007727516 hasConceptScore W3007727516C143998085 @default.
• W3007727516 hasConceptScore W3007727516C203014093 @default.
• W3007727516 hasConceptScore W3007727516C2777701055 @default.
• W3007727516 hasConceptScore W3007727516C2779079688 @default.
• W3007727516 hasConceptScore W3007727516C2779134260 @default.
• W3007727516 hasConceptScore W3007727516C2779382419 @default.
• W3007727516 hasConceptScore W3007727516C2779399171 @default.
• W3007727516 hasConceptScore W3007727516C2779559532 @default.
• W3007727516 hasConceptScore W3007727516C2780007613 @default.
• W3007727516 hasConceptScore W3007727516C2780030458 @default.
• W3007727516 hasConceptScore W3007727516C2780057760 @default.
• W3007727516 hasConceptScore W3007727516C3008058167 @default.
• W3007727516 hasConceptScore W3007727516C524204448 @default.
• W3007727516 hasConceptScore W3007727516C71924100 @default.
• W3007727516 hasConceptScore W3007727516C8891405 @default.
• W3007727516 hasIssue "1" @default.
• W3007727516 hasLocation W30077275161 @default.
• W3007727516 hasLocation W30077275162 @default.
• W3007727516 hasLocation W30077275163 @default.
• W3007727516 hasLocation W30077275164 @default.
• W3007727516 hasOpenAccess W3007727516 @default.
• W3007727516 hasPrimaryLocation W30077275161 @default.
• W3007727516 hasRelatedWork W2155654588 @default.
• W3007727516 hasRelatedWork W2751400660 @default.
• W3007727516 hasRelatedWork W2785808209 @default.
• W3007727516 hasRelatedWork W2802256694 @default.
• W3007727516 hasRelatedWork W2969038597 @default.
• W3007727516 hasRelatedWork W3007727516 @default.
• W3007727516 hasRelatedWork W3016783954 @default.
• W3007727516 hasRelatedWork W3021504039 @default.
• W3007727516 hasRelatedWork W3215044659 @default.
• W3007727516 hasRelatedWork W4283267403 @default.

• next